Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1993 1
1994 1
1995 1
1996 4
1997 4
1998 2
1999 5
2000 7
2001 4
2002 3
2003 6
2004 10
2005 10
2006 6
2007 4
2008 4
2009 7
2010 6
2011 4
2012 8
2013 7
2014 4
2015 3
2016 2
2017 8
2018 5
2019 5
2020 3
Text availability
Article attribute
Article type
Publication date

Search Results

128 results
Results by year
Filters applied: . Clear all
Page 1
Cytokine gene therapy for malignant glioma.
Okada H, Pollack IF. Okada H, et al. Expert Opin Biol Ther. 2004 Oct;4(10):1609-20. doi: 10.1517/14712598.4.10.1609. Expert Opin Biol Ther. 2004. PMID: 15461572 Review.
Cell therapies in neuro-oncology.
Pellegatta S, Finocchiaro G. Pellegatta S, et al. Neurol Sci. 2005 May;26 Suppl 1:S43-5. doi: 10.1007/s10072-005-0405-x. Neurol Sci. 2005. PMID: 15883693
[Immunotherapy in brain tumors].
De Carli E, Delion M, Rousseau A. De Carli E, et al. Ann Pathol. 2017 Feb;37(1):117-126. doi: 10.1016/j.annpat.2016.12.001. Epub 2017 Jan 19. Ann Pathol. 2017. PMID: 28111040 Review. French.
Gene therapy-mediated reprogramming tumor infiltrating T cells using IL-2 and inhibiting NF-κB signaling improves the efficacy of immunotherapy in a brain cancer model.
Mineharu Y, Muhammad AK, Yagiz K, Candolfi M, Kroeger KM, Xiong W, Puntel M, Liu C, Levy E, Lugo C, Kocharian A, Allison JP, Curran MA, Lowenstein PR, Castro MG. Mineharu Y, et al. Neurotherapeutics. 2012 Oct;9(4):827-43. doi: 10.1007/s13311-012-0144-7. Neurotherapeutics. 2012. PMID: 22996231 Free PMC article.
128 results
Jump to page
Feedback